Atlas Trials

A Trial to Assess the Antipsychotic Efficacy of ITI-007 Over 6 Weeks of Treatment

Clinical trial NCT02469155 · COMPLETED

Trial details

NCT number
NCT02469155
Sponsor
Intra-Cellular Therapies, Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Schizophrenia
Start date
2015-06-01
Primary completion
2016-08-01
Enrollment
696

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.